Collegium Pharmaceutical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 11:38:09 ET COLL

Published on 05/07/2026 at 11:38 am EDT

Collegium Pharmaceutical, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net income was USD 14.5 million compared to USD 2.42 million a year ago. Basic earnings per share from continuing operations was USD 0.45 compared to USD 0.08 a year ago.

Diluted earnings per share from continuing operations was USD 0.4 compared to USD 0.07 a year ago.